放射性^(131)I治疗分化型甲状腺癌术后转移临床分析  

Clinical analysis of radioactive ^(131)I treatment of differentiated thyroid cancer metastasis

作　　者：孙东兵[1] 孙凤英[1] 邵明华[1] 董福连[1] 

机构地区：[1]山东省单县中心医院(济宁医学院附属湖西医院)核医学科,山东单县274300

出　　处：《中国当代医药》2010年第8期29-30,共2页China Modern Medicine

摘　　要：目的:分析放射性131I治疗分化型甲状腺癌术后转移灶的临床观察和远期随访结果。方法:根据患者残留甲状腺组织大小和摄碘率,合理应用131I投放剂量,每位患者治疗1～4个疗程,每个疗程间隔3～8个月,并对22例患者的治疗结果作一疗效分析。结果:22例患者共经49次治疗,有效22例(100%),清除12例(57%),无效0例。结论:放射性131I甲状腺手术彻底、单发软组织转移且转移灶肿块较小者治疗效果较好,反之较差。"手术﹢131I治疗﹢甲状腺素抑制"是最佳分化型甲状腺癌综合治疗方案,这一方案可有效降低复发率和转移率。Objective： To study the analysis of radioactive ^131I treatment of differentiated thyroid cancer metastases after clinical observation and long-term follow-up results. Methods： Patients with residual thyroid tissue according to the size and iodine intake rate, a reasonable dose of ^131I-running, each patient were treated 1 to 4 courses, each course of treatment interval of 3 to 8 months. And an effective analysis of treatment outcomes of 22 patients were made. Results： A total of 22 patients were treated of 49 treatments,22 cases had effect （100%）, 12 cases were cleared （57%）, 0 cases was without effect. Conclusion：Total thyroidectomy alone, become soft and the organization of the transfer of the lesser of metastatic tumor treatment better, otherwise poor. ＂The operation was ＋^131I ＋ thyroxine suppression therapy,＂ This is the best comprehensive treatment of differentiated thyroid cancer program, the program can effectively reduce the incidence of recurrence and metastasis.

关 键 词：放射性131I 分化型甲状腺癌 转移灶 

分 类 号：R736.1[医药卫生—肿瘤]